No Data
No Data
Disc Medicine Price Target Maintained With a $85.00/Share by Cantor Fitzgerald
Express News | Disc Medicine Expands Leadership Team With Appointment of Industry Veteran Steve Caffé, Md as Chief Regulatory Officer
Press Release: Disc Medicine Expands Leadership Team With Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer
Disc Medicine's Chief Medical Officer Sells Shares Worth Over $71k
HC Wainwright & Co. Reiterates Buy on Disc Medicine, Maintains $70 Price Target
H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $70
H.C. Wainwright analyst Douglas Tsao maintains $Disc Medicine(IRON.US)$ with a buy rating, and maintains the target price at $70.According to TipRanks data, the analyst has a success rate of 45.8%